Caliway Biopharmaceuticals Co., Ltd. (TPEX: 6919)
541.00
-14.00 (-2.52%)
Sep 10, 2024, 2:59 PM CST
Caliway Biopharmaceuticals Revenue
Caliway Biopharmaceuticals had revenue of 7.85M TWD in the quarter ending June 30, 2024, a decrease of -31.92%. This brings the company's revenue in the last twelve months to 35.52M, up 26.93% year-over-year. In the year 2023, Caliway Biopharmaceuticals had annual revenue of 38.93M with 203.68% growth.
Revenue (ttm)
35.52M
Revenue Growth
+26.93%
P/S Ratio
2,011.32
Revenue / Employee
n/a
Employees
n/a
Market Cap
75.43B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 38.93M | 26.11M | 203.68% |
Dec 31, 2022 | 12.82M | 481.00K | 3.90% |
Dec 31, 2021 | 12.34M | 1.99M | 19.22% |
Dec 31, 2020 | 10.35M | -8.30M | -44.50% |
Dec 31, 2019 | 18.65M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition